Model
Edge
Sonnet Biotherapeutics Holdings Inc.
SONN
Filing Type
8-K
Filing Date
12/2/2025
Updated
12/3/25, 6:00 AM
Copy Ref
Filing
8-K
Earnings Release
Exhibits
8-K
Completing Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Unregistered Sales of Equity Securities, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws, Shareholder votes, Reg.
EX-2.1
EX-2.1
EX-2.2
EX-2.2
EX-3.1
EX-3.1
EX-99.1
Completing Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Unregistered Sales of Equity Securities, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws, Shareholder votes, Reg.